Atlas Trials

The Effect of Intranasal Insulin on Hepatic and Intestinal Triglyceride-rich Lipoprotein Production

Clinical trial NCT03141827 · COMPLETED

Trial details

NCT number
NCT03141827
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hyperlipidemia
Start date
2016-04-14
Primary completion
2017-02-15
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.